Optimisticc
Opportunity To Investigate the Microbiome’s Impact on Science and Treatment In Colorectal Cancer
A Cancer Grand Challenges project funded by Cancer Research UK.
OPTIMISTICC joins Colorectal Cancer Canada in Upcoming Webinar
On April 20th at 10:00 am EDT, join Colorectal Cancer Canada and the Cancer Grand Challenges OPTIMISTICC team for a webinar and live Q&A exploring our research on Colorectal Cancer and the Microbiome.
The webinar will feature a series of informal conversations with the OPTIMISTICC researchers and patient advocates, with the aim of educating the public about the role of the gut microbiome in human health and disease and its associations with colorectal cancer.
About the Program
We are an international team working together to understand the colorectal cancer microbiome: what it is, how it is associated with cancer, and what treatments will affect the microbiome to promote health.
Our objectives are to:
- Map the colorectal cancer microbiome
- Develop microbiome-targeted therapies for colorectal cancer
- Share and disseminate our findings
What’s New
Mr. Barry D Stein received the 2021 Canadian Cancer Research Alliance’s award for Exceptional Leadership in Patient Involvement in Cancer Research.
Barry is the President and CEO of Colorectal Cancer Canada and a patient advocate on our OPTIMISTICC team. He...
Metatranscriptomics (“MTX”) is a powerful method for measuring microbial gene expression
Metatranscriptomics (abbreviated "MTX") is a powerful method for measuring the gene expression (functional activity)...
BRAF mutation changes the characteristics of colorectal cancers in a mouse model
In a recent publication, the Sears lab showed that introduction of the BRAFV600E mutation into mice colonized with...
Our Sponsor
OPTIMISTICC is a Cancer Grand Challenges team funded by Cancer Research UK.
Our Partners
